期刊文献+

肿瘤坏死因子alpha上调人结肠癌细胞株突变型p53蛋白的表达 被引量:1

Effect of tumor necrosis factor alpha on mutant p53 protein expression in colorectal cancer cell lines
下载PDF
导出
摘要 目的:研究TNF-alpha对人结肠癌细胞株HT-29及HCT116 p53表达的影响。方法:给予人结肠癌细胞株HT-29(表达突变型p53蛋白)及HCT116(表达野生型p53蛋白)不同浓度的TNF-alpha刺激后,应用细胞免疫荧光及实时荧光定量PCR检测突变型p53蛋白表达及p53 mRNA水平的改变。结果:免疫荧光显示TNF-alpha刺激后能显著提高HT-29细胞核突变型p53蛋白的表达(P<0.05),而对表达野生型p53的HCT116的p53水平无明显改变。实时荧光定量PCR结果表明TNF-alpha刺激对HT-29及HCT-116的p53 mRNA水平无明显改变。结论:TNF-alpha能显著上调HT-29突变型p53蛋白的表达,但是该上调作用并不是发生于转录水平。TNF-alpha刺激对表达野生型p53的HCT116细胞株p53水平无明显改变。 Objectives: To evaluate the effect of TNF-alpha on mutant p53 expression in colorectal cancer cell lines.Methods: The cell lines HT-29(which expresses mutant p53) and HCT116(which expresses wild-type p53) were stimulated with TNF-alpha at different concentrations.Immunofluorescence and real-time quantitative RT-PCR were performed to detect the alterations of p53 protein and transcripts.Results: Immunofluorescence indicated that TNF-alpha can markedly induce nuclear p53 protein expression in HT-29 cells;in contrast,the effect of TNF-alpha on p53 expression in HCT116 cells was minimal.Real-time quantitative RT-PCR showed no substantial change of p53 mRNA in HT-29 or HCT116 cells after stimulation with TNF-alpha.Conclusions: TNF-alpha can dramatically induce nuclear mutant p53 protein expression in HT-29 cell line which expresses mutant p53,and this induction wasn't ascribed to the transcription upregulation.But this p53-induction effect of TNF-alpha was minimal in HCT116 cell line which expresses wild-type p53.Our findings suggest that TNF-alpha may be a risk factor in the carcinogenesis of IBD patients carrying a p53 mutation.
出处 《中国现代普通外科进展》 CAS 2011年第1期17-19,23,共4页 Chinese Journal of Current Advances in General Surgery
关键词 肿瘤坏死因子alpha 结肠肿瘤 P53蛋白 Tumor necrosis factor alpha·Colorectal neoplasms·p53
  • 相关文献

参考文献6

  • 1Chakravarty EF,Michaud K,Wolfe F.Skin cancer,rheumatoid arthritis,and tumor necrosis factor inhibitom[J].J Rheumatol,2005,32(11):2130-2135.
  • 2Kristy Boggs,David Reisman C.EBP befa participate in regulating transcription of the p53 gene in response to mitogen stimulation[J].J Biol chem,2007,282(11):7982-7990.
  • 3任爱民,侯英勇,许华,屠蕊沁.p53野生型与突变型上皮性卵巢癌临床病理特征比较[J].中国临床医学,2009,16(2):247-248. 被引量:4
  • 4Bongartz T,Sutton AJ,Sweeting MJ,et al.Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies:systematic review and meta-analysis of rare harmful effects in randomized controlled trials[J].JAMA,2006,95(19):2275-2285.
  • 5The Wegener's Granulomatosis Etamercept Trial(WGET)Resetrcle Group.Etonercept plus standard therapy for Wegener's granulomatosis[J].N Engl J Med,2005,52(4):351-361.
  • 6Steven H Itzkowitz.Cancer in inflammatory bowel disease[J].World Journal of Gastroenterology,2008,14(3):378-389. 被引量:33

二级参考文献123

  • 1Mazars R, Pujol P, Maudelonde T, et al. p53 mutations in ovarian cancer: a late event? [J].Oncogene,1991,6(9):1685 -1690.
  • 2Sagarra RA, Andrade LA, Martima EZ, et al. P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer[J].Int J Gynecol Cancer, 2002, 12:720.
  • 3Shihand IM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis[J]. American Journal of Pathology, 2004,164(5):1511-1518.
  • 4Landen Jr CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer[J]. J Clin Oncol, 2008, 26: 995-1005.
  • 5[1]Crohn BB,Rosenberg H.The sigmoidoscopic picture of chronic ulcerative colitis.Am J Med Sci 1925; 170:220-228
  • 6[2]Eaden JA,Abrams KR,Mayberry JF.The risk of colorectal cancer in ulcerative colitis:a meta-analysis.Gut 2001; 48:526-535
  • 7[3]Sachar DB.Cancer in Crohn's disease:dispelling the myths.Gut 1994; 35:1507-1508
  • 8[4]Bernstein CN,Blanchard JF,Kliewer E,Wajda A.Cancer risk in patients with inflammatory bowel disease:a population-based study.Cancer 2001; 91:854-862
  • 9[5]Kinzler KW,Vogelstein B.Lessons from hereditary colorectal cancer.Cell 1996; 87:159-170
  • 10[6]Fearnhead NS,Britton MP,Bodmer WF.The ABC of APC.Hum Mol Genet 2001; 10:721-733

共引文献35

同被引文献15

  • 1Zhang XW,Diao SY,Rao Q. Identification of a novel isoform of iASPP and its interaction with p53[J].Journal of Molecular Biology,2007,(04):1162-1171.
  • 2Lengauer C,Kinzler KW,Vogelstein B. Genetic instabilities in human cancers[J].Nature,1998,(6712):643-649.
  • 3Roos WP,Kaina B. DNA damage-induced cell death by apoptosis[J].Trends in Molecular Medicine,2006,(09):440-450.doi:10.1016/j.molmed.2006.07.007.
  • 4Hofseth LJ,Hussain SP,Harris CC. p53:25 years after its discovery[J].Trends in Pharmacological Sciences,2004,(04):177-181.doi:10.1016/j.tips.2004.02.009.
  • 5Lu X. p53:a heavily dictated dictator of life and death[J].Current Opinion in Genetics and Development,2005,(01):27-33.
  • 6Yang JP,Hori M,Sanda T. Identification of a novel inhibitor of nuclear factor-kappaB,RelA-associated inhibitor[J].Journal of Biological Chemistry,1999,(22):15662-15670.
  • 7Zhang XW,Wang M,Zhou CL. The expression of iASPP in acute leukemias[J].Leukemia Research,2005,(02):179-183.
  • 8Li S,Shi G,Yuan H. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP[J].Oncology Reports,2012,(01):133-140.
  • 9Liu T,Li L,Yang W. iASPP is important for bladder cancer cell proliferation[J].Oncology Research,2011,(3-4):125-130.
  • 10Lin BL,Xie DY,Xie SB. Down-regulation of iASPP in human hepatocellular carcinoma cells inhibits cell proliferation and tumor growth[J].Neoplasma,2011,(03):205-210.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部